WHO Pharmaceuticals Newsletter 1997, No. 11&12
(1997; 24 pages)
Table of Contents
Open this folder and view contentsRegulatory actions
Close this folderDrug surveillance
View the documentAlendronic acid - oesophagitis: Australia
View the documentBenzodiazepines in pregnancy and lactation - reminder: to be avoided: United Kingdom
View the documentDrug-induced gynaecomastia - review of reports: Australia
View the documentGinkgo biloba - spontaneous haemorrhage: New Zealand
View the documentHydroxyamfetamine/tropicamide (ParemydR) - adverse reactions: United States of America
View the documentMethotrexate (low-dose) - blood dyscrasias and other adverse reactions: United Kingdom
View the documentPethidine - convulsions: Australia
View the documentPyrithyldione/diphenhydramine - agranulocytosis: Spain
View the documentTherapeutic switches - evaluation of risks: call for data: United States of America
Open this folder and view contentsNew developments
Open this folder and view contentsMedical devices
Open this folder and view contentsGeneral information
Open this folder and view contentsVeterinary medicine
 

Benzodiazepines in pregnancy and lactation - reminder: to be avoided: United Kingdom

United Kingdom. The Committee on Safety of Medicines has issued a reminder that the use of benzodiazepines should be avoided during pregnancy and lactation. The following points were highlighted:

. Benzodiazepines cross the placenta and there is a risk of adverse effects in the fetus. If benzodiazepines are administered at high doses, during late pregnancy or during labour, effects on the neonate may occur, such as hypothermia, hypotonia and moderate respiratory depression.

. Infants born to mothers who take benzodiazepines chronically during the latter stages of pregnancy may develop physical dependence and be at risk of developing withdrawal symptoms in the post-natal period (irritability or difficulty with feeding).

. If a benzodiazepine is prescribed to a woman of childbearing potential, she should be advised to contact her physician regarding discontinuation of the drug if she intends to become pregnant or suspects that she is pregnant.

. Since benzodiazepines are excreted in breast milk, they should not be given to lactating mothers.

Reference: Current Problems in Pharmacovigilance Vol. 23, September 1997.

.
.

to previous section to next section
 

Last updated: May 3, 2013